Hannah Heffron

• Increased year over year revenue by 22%.

- 2023 revenue: $1,025,136

- 2024 revenue: $1,245,802

• Managed six states, while also leading a team of 8 distributor reps to expand market coverage and drive revenue growth within Academic and BioTech sectors.
• Reached 95% quota in my first year and 101% quota in my second year for Fetal Bovine Serum.
• Presented and converted Moffitt Cancer Center and Cellectis to GeminiBio Human Serum, securing multiple opportunities worth $150,000 and $325,000 in orders.

• Increased year over year business by 35% in territory through constant support and education.
• Launched new product, ConvaMax, and reached 102% sales quota 2021.
• Presented new cost savings initiatives to Henry Ford Health System and Detroit Medical Center which led to evaluations of products- $300,000 opportunity at each System.
• Established successful account relationships with key players (Physicians, Value Analysis Committee, Materials Management, Infection Control etc.) by building rapport and maintaining consistent communication.

• Grew Territory 75% year over year.
• Completed conversion of upgraded product at major hospitals such as Metro Health, Sparrow, and Bronson resulting in $250,000 increased sales throughout territory.
• Prospected and coordinated lunches with Vascular Surgeons at Borgess to help drive product sales.

• Scheduled and conducted week long virtual inservice on Bowel Management System at Henry Ford Health System which resulted in $200,000 conversion.
• Scheduled and conducted week long in person inservice on Bowel Management System at Cleveland Clinic which resulted in $150,000 conversion.

• Exceeded 120% of quota second/third quarter.
• Rank 7/25 Account Managers
• Partner with Regional Sales Manager to formulate business plans to target key accounts.